The 54 references in paper A. Kuzovlev N., V. Moroz V., A. Golubev M., S. Polovnikov G., А. Кузовлев Н, В. Мороз В, А. Голубев М, С. Половников Г. (2013) “Ингаляционные антибиотики в лечении тяжелой нозокомиальной пневмонии // Inhaled Antibiotics in the Treatment of Nosocomial Pneumonia” / spz:neicon:reanimatology:y:2013:i:6:p:61

1
Matkevich V.A., Luzhnikov E.A., Ilyashenko K.K., Petrov S.N., Nikulina V.P., Evdokimova N.V.Vliyanie kishechnogo lavazha na razvitie pnevmonii u bolnykh s ostrymi otravleniyami psikhofarmakologicheskimi sredstvami. [Impact of intestinal lavage on the development of pneumonia in patients with acute poisonings by psychopharmacological agents]. Obshchaya Reanimatologiya. 2011; 7 (2): 20—24. [In Russ.]
(check this in PDF content)
2
Smelaya T.V., Salnikova L.E., Moroz V.V., Golubev A.M., Zarzhetsky Yu.V., Rubanovich A.V. Genetichesky polimorfizm i chastota razvitiya oslozhnenii pri pnevmonii razlichnogo genezisa. [Genetic polymorphism and the rate of development of complications in pneumonia of varying genesis]. Obshchaya Reanimatologiya. 2011; 7 (2): 10—16. [In Russ.]
(check this in PDF content)
3
Khubutiya M.Sh., Shabanov A.K., Chernenkaya T.V., Godkov M.A., Dorfman A.G. Infektsionnye legochnye oslozhneniya v reanimatsii i intensivnoi terapii u postradavshikh s sochetannoi travmoi. [Infectious pulmonary complications in intensive care unit victims with concomitant injury]. Obshchaya Reanimatologiya.2011; 7 (4): 24—27. [In Russ.]
(check this in PDF content)
4
Chuchalin A.G. (red.).Nozokomialnaya pnevmoniya u vzroslykh. Natsionalnye rekomendatsii. [Nosocomial pneumonia in adults. National guidelines]. Moscow: Pfaizer; 2009: 92. [In Russ.]
(check this in PDF content)
5
Bekaert M., Timsit J.F., Vansteelandt S., Depuydt P., Ve ́sin A., GarrousteOrgeas M., Decruyenaere J., Clec’h C., Azoulay E., Benoit D.; Outcomerea Study Group. Attributable mortality of ventilatorassociated pneumonia: a reappraisal using causal analysis. Am. J. Respir. Crit. Care Med.2011; 184 (10): 1133–1139. http://dx.doi.org/10.1164/rccm.2011050867OC. PMID: 21852541
(check this in PDF content)
6
Karpun N.A., Moroz V.V., Klimova G.M.Profilaktika nozokomialnykh infektsii dykhatelnykh putei. [Prevention of nosocomial infections of the respiratory tract]. Obshchaya Reanimatologiya. 2007; 3 (3): 100—104. [In Russ.]
(check this in PDF content)
7
Shabanov A.K., Khubutiya M.Sh., Bulava G.V., Beloborodova N.V., Kuzovlev A.N., Grebenchikov O.A., Kosolapov D.A., Shpitonkov M.I. Dinamika urovnya prokaltsitonina pri razvitii nozokomialnoi pnevmonii u postradavshikh s tyazheloi sochetannoi travmoi v otdelenii reanimatologii. [Time course of changes in the level of procalcitonin in the development of nosocomial pneumonia in victims with severe concomitant injury in an intensive care unit]. Obshchaya Reanimatologiya. 2013; 9 (5): 11—18. [In Russ.]
(check this in PDF content)
8
Moroz V.V., Smelaya T.V., Golubev A.M., Salnikova L.E.Genetika i meditsina kriticheskikh sostoyanii: ot teorii k praktike. [Genetics and medicine of critical conditions: from theory to practice]. Obshchaya Reanimatologiya. 2012; 8 (4): 5—12. [In Russ.]
(check this in PDF content)
9
Golubev A.M., Smelaya T.V., Moroz V.V., Popov A.A., Tolbatov A.A., Medunetskaya S.V. Vnebolnichnaya i nozokomialnaya pnevmoniya: kliniko-morfologicheskie osobennosti. [Community-acquired and nosocomial pneumonia: Clinical and morphological features]. Obshchaya Reanimatologiya. 2010; 6 (3): 5—14. [In Russ.]
(check this in PDF content)
10
Chuchalin A.G. (red.).Respiratornaya meditsina. Rukovodstvo. [Respiratory medicine. A manual]. Moscow: GEOTAR-Media; 2007: 757. [In Russ.]
(check this in PDF content)
11
Valencia M., Torres A.Ventilator-associated pneumonia. Curr. Opin. Crit. Care. 2009; 15 (1): 30—35. http://dx.doi.org/10.1097/MCC. 0b013e3283220e78. PMID: 19186407
(check this in PDF content)
12
Gilbert D.N., Moellering R.C., Eliopoulos G.M., Chambers H.F., Saag M.S. The Sanford guide to antimicrobial therapy 2012. Antimicrobial Therapy Inc.; 2012: 232.
(check this in PDF content)
13
Koulenti D., Lisboa T., Brun-Buisson C., Krueger W., Macor A., SoleViolan J., Diaz E., Topeli A., DeWaele J., Carneiro A., Martin-Loeches I., Armaganidis A., Rello J.; EU-VAP/CAP Study Group.Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit. Care Med.2009; 37 (8): 2360—2368. http://dx.doi.org/10.1097/CCM. 0b013e3181a037ac.PMID: 19531951
(check this in PDF content)
14
Moroz V.V., Kuzovlev A.N., Polovnikov S.G., Stets V.V., Varvarin V.V. Ingalyatsionnyi tobtamitsin v lechenii tyazhelykh nozokomialnykh pnevmonii. [Inhaled tobramycin in the treatment of severe nosocomial pneumonias]. Obshchaya Reanimatologiya. 2012; 8 (2): 5—10. [In Russ.]
(check this in PDF content)
15
Polovnikov S.G., Kuzovlev A.N., Ilyichev A.N.Opyt ispolzovaniya ingalyatsionnogo tobramitsina v lechenii tyazheloi nozokomialnoi pnevmonii. [Experience with inhaled tobramycin in the treatment of severe nosocomial pneumonia]. Pulmonologiya.2011; 2: 109—112. [In Russ.]
(check this in PDF content)
16
Kuzovlev A., Polovnikov S., Stec V., Varvarin V.Efficacy of inhaled tobramycin in severe nosocomial pneumonia. Crit. Care.2012; 16 (Suppl 1): P71. http://dx.doi.org/10.1186/cc10678.
(check this in PDF content)
17
Tamma P.D., Putcha N., Suh Y.D., Van Arendonk K.J., Rinke M.L.Does prolonged beta-lactam infusions improve clinical outcomes compared to intermittent infusions? A metaanalysis and systematic review of randomized, controlled trials. BMC Infect. Dis.2011; 11: 181. http://dx.doi.org/10.1186/1471-2334-11-181. PMID: 21696619
(check this in PDF content)
18
Falagas M.E., Tansarli G.S., Ikawa K., Vardakas K.Z.Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: A systematic review and metaanalysis. Clin. Infect. Dis.2013; 56 (2): 272–282. http://dx.doi.org/10. 1093/cid/cis857. PMID: 23074314
(check this in PDF content)
19
Ehrmann S., Roche-Campo F., Sferrazza Papa G.F., Isabey D., Brochard L., Apiou-Sbirlea G.; REVA Research Network.Aerosol therapy during mechanical ventilation: an international survey. Intensive Care Med.
(check this in PDF content)
20
3; 39 (6): 1048—1056. http://dx.doi.org/10.1007/s00134-0132872-5. PMID: 23525741 20.Palmer L.B.Aerosolized antibiotics in the intensive care unit. Clin. Chest Med.2011; 32 (3): 559—574. http://dx.doi.org/10.1016/j.ccm. 2011.05.012. PMID: 21867823
(check this in PDF content)
21
Tolker-Nielsen T., Høiby N.Extracellular DNA and F-actin as targets in antibiofilm cystic fibrosis therapy. Future Microbiol.2009; 4 (6): 645—647. http://dx.doi.org/10.2217/fmb.09.38. PMID: 19659420
(check this in PDF content)
22
Dhand R.The role of aerosolized antimicrobials in the treatment of ventilator-associated pneumonia. Respir. Care.2007; 52 (7): 866—884. PMID: 17594731
(check this in PDF content)
23
Ioannidou E., Siempos I., Falagas M.Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J. Antimicrob. Chemother.2007; 60 (6): 1216—1226. http://dx.doi.org/10.1093/jac/dkm385. PMID: 17934205
(check this in PDF content)
24
Hudson R., Olson Blair B.Inhaled antibiotics for Gram-negative respiratory infections. Future Med. Chem.2011; 3 (13): 1663—1677. http://dx.doi.org/10.4155/fmc.11.114. PMID: 21942255
(check this in PDF content)
25
Le J., Ashley E.D., Neuhauser M.M., Brown J., Gentry C., Klepser M.E., Marr A.M., Schiller D., Schwiesow J.N., Tice S., VandenBussche H.L., Wood G.C.; Society of Infectious Diseases Pharmacists Aerosolized Antimicrobials Task Force. Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy.2010; 30 (6): 562—584. http://dx.doi.org/10.1592/phco.30.6.562.PMID: 20500046
(check this in PDF content)
26
Korbila I., Michalopoulos A., Rafailidis P.I., Nikita D., Samonis G., Falagas M.E. Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilatorassociated pneumonia: a comparative cohort study. Clin. Microbiol. Infect.2010; 16 (8): 1230—1236. http://dx.doi.org/10.1111/j.14690691.2009.03040.x. PMID: 19732088
(check this in PDF content)
27
Michalopoulos A., Fotakis D., Virtzili S., Vletsas C., Raftopoulou S., Mastora Z., Falagas M.E.Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir. Med.2008; 102 (3): 407—412. A 25-fold increase over the minimal inhibitory concentration is required to overcome this inactivation. Changes of physico-chemical properties of IA during the aerosol formation due to heating, cooling, vibration, etc. (more profound in jet nebulizers), local and systemic toxic effects, bronchoconstrictive effects of conservatives should be noted. The bronchospasm is mostly induced by the inhaled colistin. Only special preparations for inhalation must be used to prev
(check this in PDF content)
28
Michalopoulos A., Papadakis E.Inhaled anti-infective agents: emphasis on colistin. Infection. 2010; 38 (2): 81—88. http://dx.doi.org/ 10.1007/s15010-009-9148-6. PMID: 20191398
(check this in PDF content)
29
Avdeyev S.N., Karchevskaya N.A., Chuchalin A.G.Opyt ispolzovaniya ingalyatsionnogo tobramitsina pri nozokomialnoi pnevmonii. [Experience with inhaled tobramycin in nosocomial pneumonia]. Lechebnoe Delo.2009; 2: 80—88. [In Russ.]
(check this in PDF content)
30
Amelina E.L., Chuchalin A.G.Ingalyatsionnyi tobramitsin v lechenii sinegnoinoi infektsii u bolnykh mukovistsidozom. [Inhaled tobramycin in the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis]. Pulmonologiya.2009; 5: 120—126. [In Russ.]
(check this in PDF content)
31
Belousov Yu.B., Zyryanov S.K., Sokolov A.V.Effektivnost i bezopasnost rastvora tobramitsina dlya ingalyatsii v lechenii sinegnoinoi infektsii pri mukovistsidoze. [Efficacy and safety of tobramycin solution for inhalations in the treatment of Pseudomonas aeruginosa infection in cystic fibrosis]. Pulmonologiya.2010; 2: 114—119. [In Russ.]
(check this in PDF content)
32
Kapranov N.I., Kashirskaya N.Yu., Rodionovich A.M., Amelina E.L., Chuchalin A.G., Gembitskaya T.E., Chermensky A.G., Orlov A.V., Varoli G., Monici Preti P.Klinicheskoe znachenie spetsialnoi aerozolnoi formy tobramitsina v lechenii khronicheskogo bronkholegochnogo protsessa u bolnykh mukovistsidozom. [Clinical value of special tobramycin aerosol formulation in the treatment of a bronchopulmonary process in patients with cystic fibrosis]. Pulmonologiya. 2008; 3: 20—27. [In Russ.]
(check this in PDF content)
33
Chermensky A.G., Gembitskaya T.E.Ispolzovanie ingalyatsionnogo tobramitsina u bolnykh mukovistsidozom. [Use of inhaled tobramycin in patients with cystic fibrosis]. Terapevtichesky Arkhiv.2010; 82 (8): 76—78. [In Russ.]
(check this in PDF content)
34
Arnold H., Sawyer A., Kollef M.Use of Adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosaand Acinetobacter baumanniiventilator-associated pneumonia. Respir. Care. 2012; 57 (8): 1226—1233. http://dx.doi.org/10.4187/respcare.01556. PMID: 22349038
(check this in PDF content)
35
Chuchalin A., Amelina E., Bianco F.Tobramycin for inhalation in cystic fibrosis: beyond respiratory improvements. Pulm. Pharmacol. Ther. 2009; 22 (6): 526—532. http://dx.doi.org/10.1016/j.pupt.2009.06.001. PMID: 19616111
(check this in PDF content)
36
Drobnic M.E., SuñéP., Montoro J.B., Ferrer A., Orriols R.Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann. Pharmacother.2005; 39 (1): 39—44. http://dx.doi.org/10.1345/aph. 1E099. PMID: 15562142
(check this in PDF content)
37
Hallal A., Cohn S.M., Namias N., Habib F., Baracco G., Manning R.J., Crookes B., Schulman C.I.Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study. Surg. Infect. (Larchmt). 2007; 8 (1): 73—82. http://dx.doi.org/10.1089/sur.2006.051. PMID: 17381399
(check this in PDF content)
38
Greally P., Whitaker P., Peckham D.Challenges with current inhaled treatments for chronic Pseudomonas aeruginosainfection in patients with cystic fibrosis. Curr. Med. Res. Opin.2012; 28 (6): 1059—1067. http://dx.doi.org/10.1185/03007995.2012.674500. PMID: 22401602
(check this in PDF content)
39
Høiby N.Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Med.2011; 9: 32. http://dx.doi.org/10.1186/1741-7015-9-32. PMID: 21463524
(check this in PDF content)
40
Ghannam D.E., Rodriguez G.H., Raad I.I., Safdar A.Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance. Eur. J. Clin. Microbiol. Infect. Dis.2009; 28 (3): 253—259. http://dx.doi.org/10.1007/s10096-008-0620-5. PMID: 18752007
(check this in PDF content)
41
Ratjen F., Munck A., Kho P., Angyalosi G.; ELITE Study Group. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax.2010; 65 (4): 286—291. http://dx.doi.org/10.1136/thx.2009.121657. PMID: 19996339
(check this in PDF content)
42
Ramsey B.W., Pepe M.S., Quan J.M., Otto K.L., Montgomery A.B., Williams-Warren J., Vasiljev K.M., Borowitz D., Bowman C.M., Marshall B.C., Marshall S., Smith A.L.Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N. Engl. J. Med.1999; 340 (1): 23—30. http://dx.doi.org/10. 1056/NEJM199901073400104. PMID: 9878641
(check this in PDF content)
43
Geller D.E., Flume P.A., Staab D., Fischer R., Loutit J.S., Conrad D.J.; Mpex 204 Study Group.Levofloxacin inhalation solution (MP—376) in patients with cystic fibrosis with Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med.2011; 183 (11): 1510—1516. http://dx.doi.org/10.1164 /rccm.201008-1293OC. PMID: 21471106
(check this in PDF content)
44
Lu Q., Yang J., Liu Z., Gutierrez C., Aymard G., Rouby J.J.; Nebulized Antibiotics Study Group.Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med.2011; 184 (1): 106—115. http://dx.doi.org/ 10.1164/rccm.201011-1894OC. PMID: 21474643
(check this in PDF content)
45
Okusanya O.O., Bhavnani S.M., Hammel J., Minic P., Dupont L.J., Forrest A., Mulder G.J., Mackinson C., Ambrose P.G., Gupta R.Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection. Antimicrob. Agents Chemother.2009; 53 (9): 3847—3854. http://dx.doi.org/ 10.1128/AAC.00872-08. PMID: 19451281
(check this in PDF content)
46
Wainwright C.E., Quittner A.L., Geller D.E., Nakamura C., Wooldridge J.L., Gibson R.L., Lewis S., Montgomery A.B.Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P.aeruginosa. J. Cyst. Fibros.2011; 10 (4): 234—242. http://dx.doi.org/ 10.1016/j.jcf.2011.02.007. PMID: 21441078
(check this in PDF content)
47
Trapnell B.C., McColley S.A., Kissner D.G., Rolfe M.W., Rosen J.M., McKevitt M., Moorehead L., Montgomery A.B., Geller D.E.; Phase 2FTI Study Group.Fosfomycin/tobramycin for inhalation (FTI): efficacy results of a phase 2 placebo-controlled trial in patients with cystic fibrosis and Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med. 2012; 185 (2): 171—178. http://dx.doi.org/10.1164/rccm.201105-0924OC. PMID: 22095545
(check this in PDF content)
48
Herrmann G., Yang L., Wu H., Song Z., Wang H., Høiby N., Ulrich M., Molin S., Riethmüller J., Döring G.Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J. Infect Dis.2010; 202 (10): 1585—1592. http://dx.doi.org/10.1086/656788. PMID: 20942647
(check this in PDF content)
49
MacLeod D.L., Barker L.M., Sutherland J.L., Moss S.C., Gurgel J.L., Kenney T.F., Burns J.L., Baker W.R.Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.J. Antimicrob. Chemother. 2009; 64 (4): 829–836. http://dx.doi.org/10.1093/jac/dkp282. PMID: 19679597
(check this in PDF content)
50
Hilas O., Ezzo D.C., Jodlowski T.Z.Doripenem (doribax), a new carbapenem antibacterial agent. Pharm. Ther.2008; 33 (3): 134–180. PMID: 19750153
(check this in PDF content)
51
Ryan G., Jahnke N., Remmington T.Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. Cochrane Database Syst Rev.2012; 12: CD008319. http://dx.doi.org/10.1002/14651858.CD008319.pub2. PMID: 23235659
(check this in PDF content)
52
Lu Q., Luo R., Bodin L., Yang J., Zahr N., Aubry A., Golmard J.L., Rouby J.J.; Nebulized Antibiotics Study Group.Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosaand Acinetobacter baumannii. Anesthesiology. 2012; 117 (6): 1335–1347. http://dx.doi.org/10.1097/ALN. 0b013e31827515de. PMID: 3132092
(check this in PDF content)
53
Moroz V.V., Kuzovlev A.N., Karpun N.A., Khoroshilov S.E., Polovnikov S.G. Ingalyatsionnye antibiotiki v lechenii nozokomialnoi pnevmonii. Metodicheskie rekomendatsii. [Inhaled antibiotics in the treatment of nosocomial pneumonias. Guidelines]. Moscow: izd-vo NIIOR RAMN; 2013: 20. [In Russ.]
(check this in PDF content)
54
Chan E.Y., Ruest A., Meade M.O., Cook D.J.Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. BMJ.2007; 334 (7599): 889. http://dx. doi.org/10.1136/bmj.39136.528160.BE. PMID: 17387118 Submited 19.08.13
(check this in PDF content)